123 Following promising preclinical findings, several clinical trials have been initiated to evaluate the neuroprotective efficacy of GLP-1RAs in diverse populations, including individuals with diabetes, those at risk of cognitive decline, and patients diagnosed with AD or PD
Sulphur burps can be an uncomfortable but common digestive side effect when starting your treatment, and they often settle as your body adjusts
Petersen said that while the initial results were a little discouraging, many in the Alzheimers community still believe that GLP-1s can potentially help treat the disease
doi: 10.1159/000362497 68
L., Hokken-Koelega, A., Ramesh, C., Turan, S., & Tauber, M
People with diabetes may have A1C checked more frequently after a treatment change or when goals are not being met and less often when results and treatment are stable